Related Experiment Video
Updated: Jul 18, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
[Clinical research in private sector: Which strategic analysis?]
A Ruffier1, Y Pointreau1, V Sacier2
1Centre Jean-Bernard, institut inter-régional de cancérologie (ILC), CCS, 64, rue de Degré, 72000 Le Mans, France; Sorecoh, centre Jean-Bernard, 64, rue de Degré, 72000 Le Mans, France; WeProm, centre Jean-Bernard, 64, rue de Degré, 72000 Le Mans, France.
Clinical research in private practice offers patient access to novel treatments and physician engagement. However, administrative burdens and competition challenge its sustainability, necessitating strategic promotion.
Area of Science:
- Clinical Medicine
- Healthcare Management
- Pharmaceutical Research
Context:
- Clinical research in private practice is growing, enhancing center attractiveness for patients and physicians.
- Private practitioners offer strengths like flexibility and autonomy, but varied medical activities can limit research focus.
- Dynamic research environments foster collaborations, enabling participation in ambitious projects.
Purpose:
- To analyze the strengths and weaknesses of clinical research conducted in private practice settings.
- To identify factors influencing the quality and time dedication to research activities in private centers.
- To explore the impact of collaborations and administrative challenges on the sustainability of private practice research.
Summary:
- Private practices leverage practitioner strengths (responsiveness, autonomy) for clinical research, attracting patients to innovative treatments.
- Challenges include time constraints due to varied medical roles and administrative burdens, impacting research quality.
- Collaborations are vital for growth and accessing ambitious projects, but legislative complexities and competition pose threats.
Impact:
- Highlights the critical role of private practice in clinical research and patient access to novel therapies.
- Underscores the need for strategies to overcome challenges and promote the long-term viability of private research.
- Emphasizes the importance of addressing administrative and legislative hurdles to support this research sector.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Hazard Ratio
For example, in a clinical trial...

